tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

CNS Pharmaceuticals Inc

CNSP
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
5.110USD
-0.010-0.20%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
7.47M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CNSP ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด CNS Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
7.47M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.21
์ฃผ๋‹น์ˆœ์ด์ต
-24.12
์ˆ˜์ต
--
์ˆœ์ด์ต
-14.86M
ROE
-298.64%
ROA
-179.17%

CNS Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 12, 2026
EPS / ์˜ˆ์ƒ
-0.38/-0.24
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
94.10%-0.38
61.43%-7.30
90.27%-9.70
96.20%-5.76
99.84%-6.42
99.84%-18.93
99.69%-99.72
99.53%-151.64
87.04%-4.03K
84.27%-12.21K
71.51%-31.70K
---32.48K
---31.11K
---77.61K
---111.29K
----
----
----
----
----
์ˆœ์ด์ต
-8.97%-2.59M
-14.78%-4.94M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.30M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
2.34%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-69.17%-5.50M
10.35%-3.42M
6.50%-3.57M
12.78%-3.15M
-8.28%-3.25M
-89.67%-3.81M
๋ถ€์ฑ„๋น„์œจ
-100.00%0.00%
225.89%4.99%
1.67%3.81%
-38.37%0.26%
-83.18%0.84%
-88.06%1.53%
-78.81%3.75%
-76.62%0.42%
93.52%4.99%
229.11%12.83%
463.10%17.69%
--1.80%
--2.58%
--3.90%
--3.14%
----
----
----
----
----
์˜์—… ์ด์ต
-12.06%-2.70M
-14.70%-4.98M
-87.06%-5.99M
42.20%-3.25M
4.70%-2.41M
-22.36%-4.34M
40.51%-3.20M
-24.15%-5.63M
37.20%-2.53M
28.05%-3.54M
2.23%-5.38M
-32.61%-4.53M
-12.93%-4.03M
-56.44%-4.93M
-69.21%-5.50M
10.34%-3.42M
6.48%-3.56M
12.76%-3.15M
-8.33%-3.25M
-89.62%-3.81M
์ˆœ์ด์ต
-8.97%-2.59M
-14.78%-4.94M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.30M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
2.34%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-69.17%-5.50M
10.35%-3.42M
6.50%-3.57M
12.78%-3.15M
-8.28%-3.25M
-89.67%-3.81M
์œ ๋™์ž์‚ฐ
55.07%21.92M
-70.28%4.08M
-6.42%8.10M
54.19%11.39M
558.98%14.14M
756.94%13.72M
444.16%8.66M
258.32%7.39M
-64.66%2.15M
-77.03%1.60M
-87.34%1.59M
-76.30%2.06M
-46.73%6.07M
-52.68%6.97M
68.03%12.56M
-22.01%8.70M
-17.91%11.40M
15.23%14.73M
-51.75%7.48M
343.36%11.16M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
170.30%3.74M
64.89%4.58M
62.46%4.10M
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
226.99%4.07M
332.66%4.00M
266.87%3.92M
89.66%4.92M
-48.31%1.24M
-49.54%923.86K
-43.77%1.07M
36.15%2.59M
371.32%2.41M
์ด ์ž์‚ฐ
51.21%21.94M
-66.16%4.65M
-0.89%8.62M
60.19%11.87M
487.54%14.51M
727.83%13.75M
411.56%8.70M
218.26%7.41M
-61.73%2.47M
-77.60%1.66M
-86.97%1.70M
-75.84%2.33M
-48.17%6.45M
-53.28%7.41M
49.05%13.05M
-16.25%9.64M
-12.58%12.45M
20.75%15.87M
-44.76%8.76M
285.48%11.51M
๋ถ€์ฑ„ ์ด๊ณ„
170.30%3.74M
64.89%4.58M
62.46%4.10M
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
226.99%4.07M
332.66%4.00M
266.87%3.92M
89.66%4.92M
-48.31%1.24M
-49.54%923.86K
-43.77%1.07M
36.15%2.59M
371.32%2.41M
์ž๋ณธ ์ด๊ณ„
38.67%18.20M
-99.36%70.70K
-26.78%4.52M
195.62%9.91M
405.69%13.12M
347.60%10.97M
239.36%6.18M
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-120.74%-1.74M
-78.70%2.45M
-76.41%3.49M
31.96%8.13M
-7.76%8.39M
-7.13%11.52M
31.66%14.80M
-55.81%6.16M
267.76%9.10M
์ˆœ์˜์—…์ด์ต
33.76%-3.54M
-43.39%-4.65M
44.22%-3.05M
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-115.70%-5.47M
-101.40%-6.80M
51.50%-1.65M
33.84%-3.19M
-10.02%-2.54M
-86.25%-3.38M
-1.20%-3.40M
-56.79%-4.82M
28.78%-2.31M
9.16%-1.81M
32.72%-3.36M
6.98%-3.08M
-123.73%-3.24M
-56.67%-2.00M
์ˆœํˆฌ์ž
---3.82K
---6.18K
-333.98%-18.18K
----
----
----
-94.16%-4.19K
----
----
----
-215800.00%-2.16K
-15.19%-1.74K
----
----
100.05%1.00
---1.51K
---2.91K
100.00%0.00
---2.08K
--0.00
์ˆœ์žฌ๋ฌดํ™œ๋™
364.97%20.58M
-95.88%404.66K
-91.80%406.87K
-100.75%-91.62K
90.20%4.43M
184.17%9.83M
127.92%4.96M
146826.13%12.28M
-9.52%2.33M
2975.33%3.46M
-59.17%2.18M
107.14%8.36K
2313.46%2.57M
-101.14%-120.28K
6538.96%5.33M
-103.41%-117.14K
-114.37%-116.17K
2925.97%10.51M
-100.58%-82.83K
7735.92%3.44M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

CNS Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 8.10M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.42์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 8.62M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.89์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 4.10M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 62.46์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 4.52M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -26.78์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -15.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -7.28์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -18.18K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -333.98์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CNS Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 14.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -36.74์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -35.75์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 92.34์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -15.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.68์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 3.81์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.67์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -296.30์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 82.61์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -182.99์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.95์ž…๋‹ˆ๋‹ค.

CNS Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CNS Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -15.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -7.28์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ